Southwest Prostate Cancer Symposium™

The 23rd Annual Southwest Prostate Cancer Symposium™ 2018 (formerly Scottsdale Prostate Cancer Symposium™) will bring together world-renowned experts in the management of prostate cancer and will provide a technical update on all aspects of diagnosis and treatment of localized and advanced disease.

Program Overview:

World-renowned experts in the management of prostate cancer will provide a technical update on all aspects of diagnosis and treatment of localized and advanced disease.

Topics of discussion will include Genetic Markers, Prostate Pathology, mpMRI, Mapping Biopsy, Active Surveillance, Focal Therapy, Robotic Prostatectomy, Cryoablation, HIFU, Brachytherapy, IMRT/IGRT, New Approaches to Castrate Resistant Disease, Micronutrients, Morbidity Management and Testosterone Replacement Therapy.

This program aims to maximize the educational component and allow for time to explore all that the beautiful Scottsdale area offers in the spring.

Program Co-Chairmen

Nelson N. Stone, MD
Professor of Urology and Radiation Oncology
Icahn School of Medicine at Mount Sinai
CEO and President
3D Biopsy, Inc.
New York, New York

Richard G. Stock, MD
Professor of Radiation Oncology
Director of Genito-Urinary Radiation Oncology
The Icahn School of Medicine at Sinai School
New York, New York

Target Audience

This course is intended for urologists, radiation oncologists, medical oncologists, physicists, and other health care professionals. It will educate the attendees about advances in management of localized and advanced prostate cancer.

Accreditation

The Medical College of Wisconsin (MCW) designates this live activity for a maximum of 21.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.